Testing effectiveness (Phase 2)Looking for participantsNCT06800391
What this trial is testing
Metronomic Neoadjuvant Capecitabine and Cyclophosphamide in HUGE Pseudomyxoma Peritonei Patients
Who this might be right for
Pseudomyxoma Peritonei
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 31